Among Sanofi's top-selling drugs, sales of its cancer treatment Eloxatin and heart treatment Plavix weakened over the quarter due to competition from ...
L) will feel the pain almost immediately, announcing it will slash an additional 8000 jobs in a further cost-cutting move as it faces expected generic ...
Although many patients take these largely insurance-covered costs in stride, they still contribute significantly to the overall cost of health care. ...
Chief among them is the 2011 US expiration for Plavix, a treatment for dangerous blood clotting that brought the company $5.6 billion in revenue in 2008. ...
Patients with a particular genetic makeup do not effectively break down Plavix, an anticlotting drug. Variations in two genes affect how people re spond to ...
Pfizer's Lipitor cholesterol pill and Norvasc blood pressure treatment, as well as the Plavix blood thinner from Bristol-Myers Squibb Co. and Sanofi-Aventis ...
Several blockbuster products such as Lipitor, Plavix, Nexium, Seroquel XR and many others, worth $127 billion currently, are set to expire by 2014. ...
Email this story
